XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Nonredeemable Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Feb. 02, 2019   81,379,660       61,327,640        
Balance at beginning of period at Feb. 02, 2019 $ 853,645,000 $ 814,000 $ 523,331,000 $ 1,077,747,000 $ (126,179,000) $ (638,486,000) $ 16,418,000 $ 297,000 $ (1,684,000) $ 1,981,000
Increase (Decrease) in Stockholders' Equity                    
Net earnings (loss) 101,229,000     95,975,000     5,254,000      
Other comprehensive income (loss) (15,083,000)       (15,712,000)   629,000      
Issuance of common stock under stock compensation plans including tax effect (in shares)   1,155,166       994,519        
Issuance of common stock under stock compensation plans including income tax effect 2,801,000 $ 10,000 (8,699,000)     $ 11,490,000        
Issuance of stock under Employee Stock Purchase Plan (in shares)   53,424       53,424        
Issuance of stock under Employee Stock Purchase Plan 783,000 $ 1,000 166,000     $ 616,000        
Share-based compensation 24,290,000   24,079,000 211,000            
Dividends (41,840,000)     (41,840,000)            
Share repurchases (in shares)   16,739,740       16,739,740        
Share repurchases (288,067,000) $ (167,000) 167,000     $ (288,067,000)        
Noncontrolling interest capital distribution (668,000)           (668,000)      
Equity component value of convertible note issuance, net 42,320,000   42,320,000              
Sale of common stock warrant 28,080,000   28,080,000              
Purchase of convertible note hedge (46,440,000)   (46,440,000)              
Redeemable noncontrolling interest redemption value adjustment 0                  
Balance at end of period (in shares) at Feb. 01, 2020   65,848,510       77,019,437        
Balance at end of period at Feb. 01, 2020 661,347,000 $ 658,000 563,004,000 1,130,409,000 (139,910,000) $ (914,447,000) 21,633,000   $ 2,000,000  
Increase (Decrease) in Stockholders' Equity                    
Net earnings (loss) (80,741,000)     (81,229,000)     488,000      
Other comprehensive income (loss) 19,031,000       19,235,000   (204,000)      
Issuance of common stock under stock compensation plans including tax effect (in shares)   2,294,872       2,369,140        
Issuance of common stock under stock compensation plans including income tax effect (185,000) $ 24,000 (28,267,000)     $ 28,058,000        
Issuance of stock under Employee Stock Purchase Plan (in shares)   86,780       86,780        
Issuance of stock under Employee Stock Purchase Plan 600,000 $ 0 (427,000)     $ 1,027,000        
Share-based compensation 18,830,000   18,761,000 69,000            
Dividends (14,426,000)     (14,426,000)            
Share repurchases (in shares)   4,000,000       4,000,000        
Share repurchases (38,876,000) $ (40,000) 40,000     $ (38,876,000)        
Redeemable noncontrolling interest redemption value adjustment $ 0                  
Balance at end of period (in shares) at Jan. 30, 2021 64,230,162 64,230,162       78,563,517        
Balance at end of period at Jan. 30, 2021 $ 565,580,000 $ 642,000 553,111,000 1,034,823,000 (120,675,000) $ (924,238,000) 21,917,000      
Increase (Decrease) in Stockholders' Equity                    
Net earnings (loss) 180,049,000     171,363,000     8,686,000      
Other comprehensive income (loss) (15,840,000)       (14,874,000)   (966,000)      
Issuance of common stock under stock compensation plans including tax effect (in shares)   718,018       739,751        
Issuance of common stock under stock compensation plans including income tax effect (751,000) $ 8,000 (9,469,000)     $ 8,710,000        
Issuance of stock under Employee Stock Purchase Plan (in shares)   38,144       38,144        
Issuance of stock under Employee Stock Purchase Plan 713,000 $ 0 263,000     $ 450,000        
Share-based compensation 21,119,000   21,096,000 23,000            
Dividends (37,091,000)     (37,091,000)            
Share repurchases (in shares)   2,289,292       2,289,292        
Share repurchases (51,030,000) $ (23,000) 23,000     $ (51,030,000)        
Noncontrolling interest capital distribution (3,452,000)           (3,452,000)      
Redeemable noncontrolling interest redemption value adjustment $ (5,654,000)     (10,454,000)     4,800,000      
Balance at end of period (in shares) at Jan. 29, 2022 62,697,032 62,697,032       80,074,914        
Balance at end of period at Jan. 29, 2022 $ 653,643,000 $ 627,000 $ 565,024,000 $ 1,158,664,000 $ (135,549,000) $ (966,108,000) $ 30,985,000